Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Clinical trial NCT01624766 · COMPLETED
Trial details
- NCT number
- NCT01624766
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-19
- Primary completion
- 2021-02-24
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.